nodes	percent_of_prediction	percent_of_DWPC	metapath
Pergolide—HTR2A—enteric nervous system—Crohn's disease	0.00324	0.292	CbGeAlD
Pergolide—Cystitis noninfective—Mesalazine—Crohn's disease	0.00271	0.00412	CcSEcCtD
Pergolide—Melaena—Mesalazine—Crohn's disease	0.00271	0.00412	CcSEcCtD
Pergolide—Cystitis—Mesalazine—Crohn's disease	0.00267	0.00408	CcSEcCtD
Pergolide—Colitis—Mesalazine—Crohn's disease	0.00266	0.00405	CcSEcCtD
Pergolide—Candida infection—Mesalazine—Crohn's disease	0.00264	0.00403	CcSEcCtD
Pergolide—Vaginal infection—Mesalazine—Crohn's disease	0.00262	0.00399	CcSEcCtD
Pergolide—Osteoporosis—Prednisone—Crohn's disease	0.00261	0.00399	CcSEcCtD
Pergolide—Neuropathy—Mesalazine—Crohn's disease	0.0026	0.00396	CcSEcCtD
Pergolide—Coma—Mesalazine—Crohn's disease	0.00253	0.00386	CcSEcCtD
Pergolide—Hirsutism—Prednisone—Crohn's disease	0.00252	0.00384	CcSEcCtD
Pergolide—Bladder pain—Mesalazine—Crohn's disease	0.0025	0.00382	CcSEcCtD
Pergolide—HTR2A—myenteric nerve plexus—Crohn's disease	0.00245	0.221	CbGeAlD
Pergolide—Hypertonia—Mesalazine—Crohn's disease	0.00243	0.0037	CcSEcCtD
Pergolide—Lymphadenopathy—Mesalazine—Crohn's disease	0.00236	0.00359	CcSEcCtD
Pergolide—Ear pain—Mesalazine—Crohn's disease	0.00236	0.00359	CcSEcCtD
Pergolide—Hypothyroidism—Prednisone—Crohn's disease	0.00228	0.00348	CcSEcCtD
Pergolide—Gastroenteritis—Mesalazine—Crohn's disease	0.00227	0.00346	CcSEcCtD
Pergolide—Alopecia—Mercaptopurine—Crohn's disease	0.00227	0.00345	CcSEcCtD
Pergolide—Deafness—Mesalazine—Crohn's disease	0.00225	0.00343	CcSEcCtD
Pergolide—Eczema—Mesalazine—Crohn's disease	0.00224	0.00341	CcSEcCtD
Pergolide—Eye pain—Mesalazine—Crohn's disease	0.00223	0.0034	CcSEcCtD
Pergolide—Peptic ulcer—Prednisone—Crohn's disease	0.00219	0.00334	CcSEcCtD
Pergolide—Libido decreased—Mesalazine—Crohn's disease	0.00217	0.00331	CcSEcCtD
Pergolide—Increased appetite—Mesalazine—Crohn's disease	0.00214	0.00326	CcSEcCtD
Pergolide—Atrial fibrillation—Mesalazine—Crohn's disease	0.00212	0.00323	CcSEcCtD
Pergolide—Thirst—Mesalazine—Crohn's disease	0.00211	0.00322	CcSEcCtD
Pergolide—Dermatitis bullous—Mesalazine—Crohn's disease	0.0021	0.00321	CcSEcCtD
Pergolide—Hepatomegaly—Prednisone—Crohn's disease	0.00207	0.00316	CcSEcCtD
Pergolide—Delusion—Prednisone—Crohn's disease	0.00207	0.00316	CcSEcCtD
Pergolide—Arthritis—Mesalazine—Crohn's disease	0.00207	0.00315	CcSEcCtD
Pergolide—Anaemia—Mercaptopurine—Crohn's disease	0.00206	0.00314	CcSEcCtD
Pergolide—Mania—Prednisone—Crohn's disease	0.00202	0.00307	CcSEcCtD
Pergolide—Leukopenia—Mercaptopurine—Crohn's disease	0.002	0.00304	CcSEcCtD
Pergolide—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.00199	0.00304	CcSEcCtD
Pergolide—Affect lability—Mesalazine—Crohn's disease	0.00198	0.00302	CcSEcCtD
Pergolide—Migraine—Mesalazine—Crohn's disease	0.00198	0.00302	CcSEcCtD
Pergolide—Neuritis—Prednisone—Crohn's disease	0.00196	0.00299	CcSEcCtD
Pergolide—Glaucoma—Prednisone—Crohn's disease	0.00195	0.00297	CcSEcCtD
Pergolide—Face oedema—Mesalazine—Crohn's disease	0.00194	0.00296	CcSEcCtD
Pergolide—Mood swings—Mesalazine—Crohn's disease	0.0019	0.0029	CcSEcCtD
Pergolide—Arthralgia—Mercaptopurine—Crohn's disease	0.0019	0.0029	CcSEcCtD
Pergolide—Pancreatitis—Azathioprine—Crohn's disease	0.00187	0.00285	CcSEcCtD
Pergolide—Liver function test abnormal—Mesalazine—Crohn's disease	0.00186	0.00283	CcSEcCtD
Pergolide—Abscess—Prednisone—Crohn's disease	0.00185	0.00282	CcSEcCtD
Pergolide—Dry skin—Mesalazine—Crohn's disease	0.00184	0.00281	CcSEcCtD
Pergolide—Orthostatic hypotension—Mesalazine—Crohn's disease	0.00184	0.0028	CcSEcCtD
Pergolide—Oedema—Mercaptopurine—Crohn's disease	0.00182	0.00278	CcSEcCtD
Pergolide—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00178	0.00272	CcSEcCtD
Pergolide—Petechiae—Prednisone—Crohn's disease	0.00178	0.00272	CcSEcCtD
Pergolide—Gastritis—Mesalazine—Crohn's disease	0.00178	0.00271	CcSEcCtD
Pergolide—Endocrine disorder—Prednisone—Crohn's disease	0.00177	0.00269	CcSEcCtD
Pergolide—Abdominal distension—Mesalazine—Crohn's disease	0.00175	0.00267	CcSEcCtD
Pergolide—Asthma—Mesalazine—Crohn's disease	0.00174	0.00265	CcSEcCtD
Pergolide—Influenza—Mesalazine—Crohn's disease	0.00174	0.00265	CcSEcCtD
Pergolide—Dysphagia—Mesalazine—Crohn's disease	0.00174	0.00265	CcSEcCtD
Pergolide—Anorexia—Mercaptopurine—Crohn's disease	0.00174	0.00265	CcSEcCtD
Pergolide—Eosinophilia—Mesalazine—Crohn's disease	0.00172	0.00262	CcSEcCtD
Pergolide—Pneumonia—Azathioprine—Crohn's disease	0.00171	0.00261	CcSEcCtD
Pergolide—Delirium—Prednisone—Crohn's disease	0.0017	0.0026	CcSEcCtD
Pergolide—Pancreatitis—Mesalazine—Crohn's disease	0.0017	0.0026	CcSEcCtD
Pergolide—Angina pectoris—Mesalazine—Crohn's disease	0.00169	0.00258	CcSEcCtD
Pergolide—Bronchitis—Mesalazine—Crohn's disease	0.00167	0.00255	CcSEcCtD
Pergolide—Amenorrhoea—Prednisone—Crohn's disease	0.00167	0.00254	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00166	0.00253	CcSEcCtD
Pergolide—Dysuria—Mesalazine—Crohn's disease	0.00163	0.00248	CcSEcCtD
Pergolide—Pollakiuria—Mesalazine—Crohn's disease	0.00161	0.00245	CcSEcCtD
Pergolide—Decreased appetite—Mercaptopurine—Crohn's disease	0.00158	0.00241	CcSEcCtD
Pergolide—Weight increased—Mesalazine—Crohn's disease	0.00158	0.00241	CcSEcCtD
Pergolide—Weight decreased—Mesalazine—Crohn's disease	0.00157	0.0024	CcSEcCtD
Pergolide—Leukocytosis—Prednisone—Crohn's disease	0.00156	0.00238	CcSEcCtD
Pergolide—Pneumonia—Mesalazine—Crohn's disease	0.00156	0.00238	CcSEcCtD
Pergolide—Hypercholesterolaemia—Prednisone—Crohn's disease	0.00155	0.00236	CcSEcCtD
Pergolide—Depression—Mesalazine—Crohn's disease	0.00155	0.00236	CcSEcCtD
Pergolide—Cataract—Prednisone—Crohn's disease	0.00154	0.00235	CcSEcCtD
Pergolide—Renal failure—Mesalazine—Crohn's disease	0.00152	0.00232	CcSEcCtD
Pergolide—Neuropathy peripheral—Mesalazine—Crohn's disease	0.00152	0.00232	CcSEcCtD
Pergolide—Jaundice—Mesalazine—Crohn's disease	0.00151	0.0023	CcSEcCtD
Pergolide—Urinary tract infection—Mesalazine—Crohn's disease	0.00151	0.0023	CcSEcCtD
Pergolide—Conjunctivitis—Mesalazine—Crohn's disease	0.00151	0.0023	CcSEcCtD
Pergolide—Vasculitis—Prednisone—Crohn's disease	0.0015	0.00229	CcSEcCtD
Pergolide—Sweating—Mesalazine—Crohn's disease	0.00149	0.00226	CcSEcCtD
Pergolide—Haematuria—Mesalazine—Crohn's disease	0.00148	0.00225	CcSEcCtD
Pergolide—Hiccups—Prednisone—Crohn's disease	0.00147	0.00223	CcSEcCtD
Pergolide—Epistaxis—Mesalazine—Crohn's disease	0.00146	0.00223	CcSEcCtD
Pergolide—Sinusitis—Mesalazine—Crohn's disease	0.00145	0.00222	CcSEcCtD
Pergolide—Body temperature increased—Mercaptopurine—Crohn's disease	0.00144	0.00219	CcSEcCtD
Pergolide—Rhinitis—Mesalazine—Crohn's disease	0.00139	0.00213	CcSEcCtD
Pergolide—Hepatitis—Mesalazine—Crohn's disease	0.00139	0.00212	CcSEcCtD
Pergolide—Pharyngitis—Mesalazine—Crohn's disease	0.00138	0.0021	CcSEcCtD
Pergolide—Neuropathy—Prednisone—Crohn's disease	0.00138	0.0021	CcSEcCtD
Pergolide—Oedema peripheral—Mesalazine—Crohn's disease	0.00137	0.00209	CcSEcCtD
Pergolide—Chills—Azathioprine—Crohn's disease	0.00137	0.00209	CcSEcCtD
Pergolide—Arrhythmia—Azathioprine—Crohn's disease	0.00136	0.00208	CcSEcCtD
Pergolide—Alopecia—Azathioprine—Crohn's disease	0.00135	0.00206	CcSEcCtD
Pergolide—Oesophagitis—Prednisone—Crohn's disease	0.00134	0.00204	CcSEcCtD
Pergolide—Pulmonary oedema—Prednisone—Crohn's disease	0.0013	0.00199	CcSEcCtD
Pergolide—Eye disorder—Mesalazine—Crohn's disease	0.0013	0.00198	CcSEcCtD
Pergolide—Tinnitus—Mesalazine—Crohn's disease	0.0013	0.00198	CcSEcCtD
Pergolide—Hyperkinesia—Prednisone—Crohn's disease	0.00128	0.00195	CcSEcCtD
Pergolide—Sepsis—Prednisone—Crohn's disease	0.00127	0.00194	CcSEcCtD
Pergolide—Euphoric mood—Prednisone—Crohn's disease	0.00126	0.00192	CcSEcCtD
Pergolide—Chills—Mesalazine—Crohn's disease	0.00125	0.0019	CcSEcCtD
Pergolide—Diarrhoea—Mercaptopurine—Crohn's disease	0.00125	0.0019	CcSEcCtD
Pergolide—Ill-defined disorder—Azathioprine—Crohn's disease	0.00123	0.00188	CcSEcCtD
Pergolide—Alopecia—Mesalazine—Crohn's disease	0.00123	0.00187	CcSEcCtD
Pergolide—Thrombophlebitis—Prednisone—Crohn's disease	0.00123	0.00187	CcSEcCtD
Pergolide—Anaemia—Azathioprine—Crohn's disease	0.00123	0.00187	CcSEcCtD
Pergolide—Diabetes mellitus—Prednisone—Crohn's disease	0.00122	0.00186	CcSEcCtD
Pergolide—Malaise—Azathioprine—Crohn's disease	0.0012	0.00183	CcSEcCtD
Pergolide—Flatulence—Mesalazine—Crohn's disease	0.00119	0.00182	CcSEcCtD
Pergolide—Leukopenia—Azathioprine—Crohn's disease	0.00119	0.00181	CcSEcCtD
Pergolide—Vascular purpura—Prednisone—Crohn's disease	0.00119	0.00181	CcSEcCtD
Pergolide—Tension—Mesalazine—Crohn's disease	0.00119	0.00181	CcSEcCtD
Pergolide—Dysgeusia—Mesalazine—Crohn's disease	0.00119	0.00181	CcSEcCtD
Pergolide—Nervousness—Mesalazine—Crohn's disease	0.00118	0.00179	CcSEcCtD
Pergolide—Cardiac failure congestive—Prednisone—Crohn's disease	0.00117	0.00179	CcSEcCtD
Pergolide—Back pain—Mesalazine—Crohn's disease	0.00117	0.00179	CcSEcCtD
Pergolide—Vomiting—Mercaptopurine—Crohn's disease	0.00116	0.00176	CcSEcCtD
Pergolide—Injury—Prednisone—Crohn's disease	0.00116	0.00176	CcSEcCtD
Pergolide—Rash—Mercaptopurine—Crohn's disease	0.00115	0.00175	CcSEcCtD
Pergolide—Dermatitis—Mercaptopurine—Crohn's disease	0.00115	0.00175	CcSEcCtD
Pergolide—Tremor—Mesalazine—Crohn's disease	0.00113	0.00173	CcSEcCtD
Pergolide—Amnesia—Prednisone—Crohn's disease	0.00113	0.00173	CcSEcCtD
Pergolide—Increased appetite—Prednisone—Crohn's disease	0.00113	0.00173	CcSEcCtD
Pergolide—Arthralgia—Azathioprine—Crohn's disease	0.00113	0.00173	CcSEcCtD
Pergolide—Myalgia—Azathioprine—Crohn's disease	0.00113	0.00173	CcSEcCtD
Pergolide—Ill-defined disorder—Mesalazine—Crohn's disease	0.00112	0.00171	CcSEcCtD
Pergolide—Anaemia—Mesalazine—Crohn's disease	0.00112	0.00171	CcSEcCtD
Pergolide—Discomfort—Azathioprine—Crohn's disease	0.00112	0.0017	CcSEcCtD
Pergolide—Purpura—Prednisone—Crohn's disease	0.0011	0.00168	CcSEcCtD
Pergolide—Malaise—Mesalazine—Crohn's disease	0.00109	0.00166	CcSEcCtD
Pergolide—Vertigo—Mesalazine—Crohn's disease	0.00109	0.00166	CcSEcCtD
Pergolide—Syncope—Mesalazine—Crohn's disease	0.00109	0.00166	CcSEcCtD
Pergolide—Leukopenia—Mesalazine—Crohn's disease	0.00108	0.00165	CcSEcCtD
Pergolide—Nausea—Mercaptopurine—Crohn's disease	0.00108	0.00165	CcSEcCtD
Pergolide—Infection—Azathioprine—Crohn's disease	0.00108	0.00164	CcSEcCtD
Pergolide—Palpitations—Mesalazine—Crohn's disease	0.00107	0.00163	CcSEcCtD
Pergolide—Loss of consciousness—Mesalazine—Crohn's disease	0.00106	0.00162	CcSEcCtD
Pergolide—Thrombocytopenia—Azathioprine—Crohn's disease	0.00106	0.00162	CcSEcCtD
Pergolide—Cough—Mesalazine—Crohn's disease	0.00106	0.00161	CcSEcCtD
Pergolide—Affect lability—Prednisone—Crohn's disease	0.00105	0.0016	CcSEcCtD
Pergolide—Hypertension—Mesalazine—Crohn's disease	0.00105	0.00159	CcSEcCtD
Pergolide—Psychotic disorder—Prednisone—Crohn's disease	0.00104	0.00158	CcSEcCtD
Pergolide—Chest pain—Mesalazine—Crohn's disease	0.00103	0.00157	CcSEcCtD
Pergolide—Myalgia—Mesalazine—Crohn's disease	0.00103	0.00157	CcSEcCtD
Pergolide—Arthralgia—Mesalazine—Crohn's disease	0.00103	0.00157	CcSEcCtD
Pergolide—Anxiety—Mesalazine—Crohn's disease	0.00103	0.00157	CcSEcCtD
Pergolide—Face oedema—Prednisone—Crohn's disease	0.00103	0.00157	CcSEcCtD
Pergolide—Discomfort—Mesalazine—Crohn's disease	0.00102	0.00155	CcSEcCtD
Pergolide—Hypotension—Azathioprine—Crohn's disease	0.00101	0.00155	CcSEcCtD
Pergolide—Cardiac arrest—Prednisone—Crohn's disease	0.00101	0.00154	CcSEcCtD
Pergolide—Dry mouth—Mesalazine—Crohn's disease	0.00101	0.00154	CcSEcCtD
Pergolide—Mood swings—Prednisone—Crohn's disease	0.00101	0.00154	CcSEcCtD
Pergolide—Confusional state—Mesalazine—Crohn's disease	0.000997	0.00152	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000989	0.00151	CcSEcCtD
Pergolide—Oedema—Mesalazine—Crohn's disease	0.000988	0.00151	CcSEcCtD
Pergolide—Infection—Mesalazine—Crohn's disease	0.000982	0.0015	CcSEcCtD
Pergolide—Dry skin—Prednisone—Crohn's disease	0.000975	0.00149	CcSEcCtD
Pergolide—Shock—Mesalazine—Crohn's disease	0.000972	0.00148	CcSEcCtD
Pergolide—Hypokalaemia—Prednisone—Crohn's disease	0.000968	0.00148	CcSEcCtD
Pergolide—Thrombocytopenia—Mesalazine—Crohn's disease	0.000968	0.00147	CcSEcCtD
Pergolide—Tachycardia—Mesalazine—Crohn's disease	0.000965	0.00147	CcSEcCtD
Pergolide—Hyperhidrosis—Mesalazine—Crohn's disease	0.000955	0.00146	CcSEcCtD
Pergolide—Anorexia—Mesalazine—Crohn's disease	0.000942	0.00144	CcSEcCtD
Pergolide—Abdominal distension—Prednisone—Crohn's disease	0.000926	0.00141	CcSEcCtD
Pergolide—Hypotension—Mesalazine—Crohn's disease	0.000924	0.00141	CcSEcCtD
Pergolide—Pancreatitis—Prednisone—Crohn's disease	0.000902	0.00137	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.0009	0.00137	CcSEcCtD
Pergolide—Feeling abnormal—Azathioprine—Crohn's disease	0.000894	0.00136	CcSEcCtD
Pergolide—Insomnia—Mesalazine—Crohn's disease	0.000894	0.00136	CcSEcCtD
Pergolide—Paraesthesia—Mesalazine—Crohn's disease	0.000887	0.00135	CcSEcCtD
Pergolide—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000887	0.00135	CcSEcCtD
Pergolide—Dyspnoea—Mesalazine—Crohn's disease	0.000881	0.00134	CcSEcCtD
Pergolide—Somnolence—Mesalazine—Crohn's disease	0.000879	0.00134	CcSEcCtD
Pergolide—Dyspepsia—Mesalazine—Crohn's disease	0.00087	0.00133	CcSEcCtD
Pergolide—Decreased appetite—Mesalazine—Crohn's disease	0.000859	0.00131	CcSEcCtD
Pergolide—Abdominal pain—Azathioprine—Crohn's disease	0.000858	0.00131	CcSEcCtD
Pergolide—Body temperature increased—Azathioprine—Crohn's disease	0.000858	0.00131	CcSEcCtD
Pergolide—Erectile dysfunction—Prednisone—Crohn's disease	0.000847	0.00129	CcSEcCtD
Pergolide—Pain—Mesalazine—Crohn's disease	0.000845	0.00129	CcSEcCtD
Pergolide—Constipation—Mesalazine—Crohn's disease	0.000845	0.00129	CcSEcCtD
Pergolide—Weight increased—Prednisone—Crohn's disease	0.000837	0.00128	CcSEcCtD
Pergolide—Weight decreased—Prednisone—Crohn's disease	0.000832	0.00127	CcSEcCtD
Pergolide—Hyperglycaemia—Prednisone—Crohn's disease	0.000829	0.00126	CcSEcCtD
Pergolide—Depression—Prednisone—Crohn's disease	0.000818	0.00125	CcSEcCtD
Pergolide—Feeling abnormal—Mesalazine—Crohn's disease	0.000814	0.00124	CcSEcCtD
Pergolide—Acute coronary syndrome—Prednisone—Crohn's disease	0.000808	0.00123	CcSEcCtD
Pergolide—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000808	0.00123	CcSEcCtD
Pergolide—Neuropathy peripheral—Prednisone—Crohn's disease	0.000804	0.00122	CcSEcCtD
Pergolide—Myocardial infarction—Prednisone—Crohn's disease	0.000804	0.00122	CcSEcCtD
Pergolide—Body temperature increased—Mesalazine—Crohn's disease	0.000781	0.00119	CcSEcCtD
Pergolide—Abdominal pain—Mesalazine—Crohn's disease	0.000781	0.00119	CcSEcCtD
Pergolide—Bradycardia—Prednisone—Crohn's disease	0.000749	0.00114	CcSEcCtD
Pergolide—Diarrhoea—Azathioprine—Crohn's disease	0.000742	0.00113	CcSEcCtD
Pergolide—Hallucination—Prednisone—Crohn's disease	0.000732	0.00112	CcSEcCtD
Pergolide—Dizziness—Azathioprine—Crohn's disease	0.000718	0.00109	CcSEcCtD
Pergolide—Asthenia—Mesalazine—Crohn's disease	0.000709	0.00108	CcSEcCtD
Pergolide—Pruritus—Mesalazine—Crohn's disease	0.000699	0.00107	CcSEcCtD
Pergolide—Vomiting—Azathioprine—Crohn's disease	0.00069	0.00105	CcSEcCtD
Pergolide—Eye disorder—Prednisone—Crohn's disease	0.000688	0.00105	CcSEcCtD
Pergolide—Rash—Azathioprine—Crohn's disease	0.000684	0.00104	CcSEcCtD
Pergolide—Dermatitis—Azathioprine—Crohn's disease	0.000684	0.00104	CcSEcCtD
Pergolide—Headache—Azathioprine—Crohn's disease	0.00068	0.00104	CcSEcCtD
Pergolide—Diarrhoea—Mesalazine—Crohn's disease	0.000676	0.00103	CcSEcCtD
Pergolide—ADRA1D—epithelium—Crohn's disease	0.000658	0.0594	CbGeAlD
Pergolide—Arrhythmia—Prednisone—Crohn's disease	0.000658	0.001	CcSEcCtD
Pergolide—Dizziness—Mesalazine—Crohn's disease	0.000654	0.000996	CcSEcCtD
Pergolide—Alopecia—Prednisone—Crohn's disease	0.00065	0.000991	CcSEcCtD
Pergolide—Nausea—Azathioprine—Crohn's disease	0.000644	0.000982	CcSEcCtD
Pergolide—DRD5—lymphoid tissue—Crohn's disease	0.000632	0.057	CbGeAlD
Pergolide—Vomiting—Mesalazine—Crohn's disease	0.000628	0.000958	CcSEcCtD
Pergolide—Rash—Mesalazine—Crohn's disease	0.000623	0.00095	CcSEcCtD
Pergolide—Dermatitis—Mesalazine—Crohn's disease	0.000623	0.000949	CcSEcCtD
Pergolide—Headache—Mesalazine—Crohn's disease	0.000619	0.000944	CcSEcCtD
Pergolide—Ill-defined disorder—Prednisone—Crohn's disease	0.000594	0.000906	CcSEcCtD
Pergolide—Anaemia—Prednisone—Crohn's disease	0.000592	0.000903	CcSEcCtD
Pergolide—Agitation—Prednisone—Crohn's disease	0.000589	0.000897	CcSEcCtD
Pergolide—Nausea—Mesalazine—Crohn's disease	0.000587	0.000895	CcSEcCtD
Pergolide—Malaise—Prednisone—Crohn's disease	0.000578	0.000881	CcSEcCtD
Pergolide—Vertigo—Prednisone—Crohn's disease	0.000576	0.000877	CcSEcCtD
Pergolide—Syncope—Prednisone—Crohn's disease	0.000575	0.000876	CcSEcCtD
Pergolide—Loss of consciousness—Prednisone—Crohn's disease	0.000563	0.000858	CcSEcCtD
Pergolide—Convulsion—Prednisone—Crohn's disease	0.000555	0.000846	CcSEcCtD
Pergolide—Hypertension—Prednisone—Crohn's disease	0.000553	0.000843	CcSEcCtD
Pergolide—Arthralgia—Prednisone—Crohn's disease	0.000545	0.000831	CcSEcCtD
Pergolide—Myalgia—Prednisone—Crohn's disease	0.000545	0.000831	CcSEcCtD
Pergolide—Anxiety—Prednisone—Crohn's disease	0.000544	0.000829	CcSEcCtD
Pergolide—Discomfort—Prednisone—Crohn's disease	0.000539	0.000821	CcSEcCtD
Pergolide—Oedema—Prednisone—Crohn's disease	0.000523	0.000797	CcSEcCtD
Pergolide—Infection—Prednisone—Crohn's disease	0.00052	0.000792	CcSEcCtD
Pergolide—Shock—Prednisone—Crohn's disease	0.000514	0.000784	CcSEcCtD
Pergolide—Tachycardia—Prednisone—Crohn's disease	0.00051	0.000778	CcSEcCtD
Pergolide—Hyperhidrosis—Prednisone—Crohn's disease	0.000506	0.000771	CcSEcCtD
Pergolide—Anorexia—Prednisone—Crohn's disease	0.000498	0.00076	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000476	0.000726	CcSEcCtD
Pergolide—Insomnia—Prednisone—Crohn's disease	0.000473	0.000721	CcSEcCtD
Pergolide—Paraesthesia—Prednisone—Crohn's disease	0.00047	0.000716	CcSEcCtD
Pergolide—Dyspepsia—Prednisone—Crohn's disease	0.00046	0.000702	CcSEcCtD
Pergolide—Decreased appetite—Prednisone—Crohn's disease	0.000455	0.000693	CcSEcCtD
Pergolide—Constipation—Prednisone—Crohn's disease	0.000447	0.000682	CcSEcCtD
Pergolide—HTR2B—smooth muscle tissue—Crohn's disease	0.000441	0.0398	CbGeAlD
Pergolide—HTR2B—skin of body—Crohn's disease	0.000435	0.0393	CbGeAlD
Pergolide—Feeling abnormal—Prednisone—Crohn's disease	0.000431	0.000657	CcSEcCtD
Pergolide—Gastrointestinal pain—Prednisone—Crohn's disease	0.000428	0.000652	CcSEcCtD
Pergolide—Abdominal pain—Prednisone—Crohn's disease	0.000413	0.00063	CcSEcCtD
Pergolide—Body temperature increased—Prednisone—Crohn's disease	0.000413	0.00063	CcSEcCtD
Pergolide—ADRA1A—epithelium—Crohn's disease	0.000378	0.0341	CbGeAlD
Pergolide—Asthenia—Prednisone—Crohn's disease	0.000375	0.000572	CcSEcCtD
Pergolide—Pruritus—Prednisone—Crohn's disease	0.00037	0.000564	CcSEcCtD
Pergolide—Diarrhoea—Prednisone—Crohn's disease	0.000358	0.000545	CcSEcCtD
Pergolide—HTR2B—digestive system—Crohn's disease	0.000348	0.0314	CbGeAlD
Pergolide—Dizziness—Prednisone—Crohn's disease	0.000346	0.000527	CcSEcCtD
Pergolide—Vomiting—Prednisone—Crohn's disease	0.000332	0.000507	CcSEcCtD
Pergolide—Rash—Prednisone—Crohn's disease	0.00033	0.000503	CcSEcCtD
Pergolide—Dermatitis—Prednisone—Crohn's disease	0.000329	0.000502	CcSEcCtD
Pergolide—Headache—Prednisone—Crohn's disease	0.000328	0.000499	CcSEcCtD
Pergolide—ADRA2C—mammalian vulva—Crohn's disease	0.000312	0.0282	CbGeAlD
Pergolide—Nausea—Prednisone—Crohn's disease	0.000311	0.000473	CcSEcCtD
Pergolide—ADRA1A—lymphoid tissue—Crohn's disease	0.000291	0.0263	CbGeAlD
Pergolide—ADRA2A—mammalian vulva—Crohn's disease	0.000249	0.0225	CbGeAlD
Pergolide—HTR2A—epithelium—Crohn's disease	0.000244	0.022	CbGeAlD
Pergolide—HTR2A—smooth muscle tissue—Crohn's disease	0.000235	0.0212	CbGeAlD
Pergolide—HTR2B—lymph node—Crohn's disease	0.000199	0.0179	CbGeAlD
Pergolide—HTR2A—digestive system—Crohn's disease	0.000186	0.0168	CbGeAlD
Pergolide—CYP3A4—digestive system—Crohn's disease	0.000172	0.0155	CbGeAlD
Pergolide—CYP2D6—digestive system—Crohn's disease	0.000169	0.0153	CbGeAlD
Pergolide—KCNH2—lymph node—Crohn's disease	0.000159	0.0143	CbGeAlD
Pergolide—ADRA2C—lymph node—Crohn's disease	0.000156	0.0141	CbGeAlD
Pergolide—ADRA2A—lymph node—Crohn's disease	0.000125	0.0113	CbGeAlD
Pergolide—ADRA1A—Signaling by GPCR—IL2RA—Crohn's disease	5.77e-05	0.000173	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—RASGRP1—Crohn's disease	5.77e-05	0.000173	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—IL3—Crohn's disease	5.76e-05	0.000173	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—IL3—Crohn's disease	5.73e-05	0.000172	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—PTGER4—Crohn's disease	5.72e-05	0.000172	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—SMAD3—Crohn's disease	5.72e-05	0.000172	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—RIPK2—Crohn's disease	5.71e-05	0.000172	CbGpPWpGaD
Pergolide—HTR2B—GPCR downstream signaling—CXCL8—Crohn's disease	5.69e-05	0.000171	CbGpPWpGaD
Pergolide—HTR2B—Signaling by GPCR—JAK2—Crohn's disease	5.66e-05	0.00017	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—SMAD3—Crohn's disease	5.62e-05	0.000169	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—RIPK2—Crohn's disease	5.62e-05	0.000169	CbGpPWpGaD
Pergolide—HTR1D—Signaling by GPCR—CXCL8—Crohn's disease	5.61e-05	0.000169	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—GCKR—Crohn's disease	5.61e-05	0.000169	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—TYK2—Crohn's disease	5.59e-05	0.000168	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—IL3—Crohn's disease	5.57e-05	0.000167	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—RASGRP1—Crohn's disease	5.57e-05	0.000167	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—RASGRP1—Crohn's disease	5.54e-05	0.000166	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—TYK2—Crohn's disease	5.52e-05	0.000166	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—TYK2—Crohn's disease	5.52e-05	0.000166	CbGpPWpGaD
Pergolide—HTR1B—Signaling by GPCR—CXCL8—Crohn's disease	5.5e-05	0.000165	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—IL3—Crohn's disease	5.48e-05	0.000165	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—RBX1—Crohn's disease	5.46e-05	0.000164	CbGpPWpGaD
Pergolide—DRD4—Signaling by GPCR—CXCL8—Crohn's disease	5.41e-05	0.000162	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—IL2RA—Crohn's disease	5.41e-05	0.000162	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—RASGRP1—Crohn's disease	5.39e-05	0.000162	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—SMAD3—Crohn's disease	5.37e-05	0.000161	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—IL2RA—Crohn's disease	5.36e-05	0.000161	CbGpPWpGaD
Pergolide—DRD1—GPCR downstream signaling—CXCL8—Crohn's disease	5.36e-05	0.000161	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—UBE2D1—Crohn's disease	5.34e-05	0.000161	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—JAK2—Crohn's disease	5.33e-05	0.00016	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—PTGER4—Crohn's disease	5.31e-05	0.00016	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—RASGRP1—Crohn's disease	5.3e-05	0.000159	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—IL2RA—Crohn's disease	5.29e-05	0.000159	CbGpPWpGaD
Pergolide—ADRA1D—GPCR downstream signaling—CXCL8—Crohn's disease	5.29e-05	0.000159	CbGpPWpGaD
Pergolide—DRD3—GPCR downstream signaling—CXCL8—Crohn's disease	5.29e-05	0.000159	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—JAK2—Crohn's disease	5.26e-05	0.000158	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—JAK2—Crohn's disease	5.26e-05	0.000158	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—UBE2D1—Crohn's disease	5.26e-05	0.000158	CbGpPWpGaD
Pergolide—ADRA2B—GPCR downstream signaling—JAK2—Crohn's disease	5.23e-05	0.000157	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—SOCS1—Crohn's disease	5.22e-05	0.000157	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—IL2RA—Crohn's disease	5.21e-05	0.000156	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—MTMR3—Crohn's disease	5.21e-05	0.000156	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—RIPK2—Crohn's disease	5.18e-05	0.000156	CbGpPWpGaD
Pergolide—HTR2B—Signaling by GPCR—CXCL8—Crohn's disease	5.16e-05	0.000155	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—UBE2D1—Crohn's disease	5.15e-05	0.000155	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—RIPK2—Crohn's disease	5.1e-05	0.000153	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—SMAD3—Crohn's disease	5.06e-05	0.000152	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—IL3—Crohn's disease	5.05e-05	0.000152	CbGpPWpGaD
Pergolide—HTR1A—GPCR downstream signaling—JAK2—Crohn's disease	5.05e-05	0.000152	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—SOCS1—Crohn's disease	5.04e-05	0.000152	CbGpPWpGaD
Pergolide—HTR2C—GPCR downstream signaling—JAK2—Crohn's disease	5.03e-05	0.000151	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—SOCS1—Crohn's disease	5.02e-05	0.000151	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—SMAD3—Crohn's disease	5e-05	0.00015	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—SMAD3—Crohn's disease	5e-05	0.00015	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—RIPK2—Crohn's disease	4.99e-05	0.00015	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—TYK2—Crohn's disease	4.98e-05	0.00015	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—IL3—Crohn's disease	4.97e-05	0.000149	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—TYK2—Crohn's disease	4.97e-05	0.000149	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—IL2RA—Crohn's disease	4.97e-05	0.000149	CbGpPWpGaD
Pergolide—ADRA2C—GPCR downstream signaling—JAK2—Crohn's disease	4.89e-05	0.000147	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—RASGRP1—Crohn's disease	4.89e-05	0.000147	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—SOCS1—Crohn's disease	4.88e-05	0.000147	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—CXCL8—Crohn's disease	4.87e-05	0.000146	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—IL3—Crohn's disease	4.87e-05	0.000146	CbGpPWpGaD
Pergolide—ADRA1B—GPCR downstream signaling—JAK2—Crohn's disease	4.81e-05	0.000145	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—RASGRP1—Crohn's disease	4.81e-05	0.000144	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—TYK2—Crohn's disease	4.81e-05	0.000144	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—CXCL8—Crohn's disease	4.8e-05	0.000144	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—CXCL8—Crohn's disease	4.8e-05	0.000144	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—SOCS1—Crohn's disease	4.8e-05	0.000144	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—TYK2—Crohn's disease	4.78e-05	0.000144	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—UBE2D1—Crohn's disease	4.78e-05	0.000144	CbGpPWpGaD
Pergolide—ADRA2B—GPCR downstream signaling—CXCL8—Crohn's disease	4.78e-05	0.000143	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—JAK2—Crohn's disease	4.75e-05	0.000143	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—JAK2—Crohn's disease	4.74e-05	0.000142	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—RASGRP1—Crohn's disease	4.71e-05	0.000141	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—IL2RA—Crohn's disease	4.69e-05	0.000141	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—TYK2—Crohn's disease	4.65e-05	0.00014	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—RIPK2—Crohn's disease	4.64e-05	0.000139	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—IL2RA—Crohn's disease	4.63e-05	0.000139	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—IL2RA—Crohn's disease	4.63e-05	0.000139	CbGpPWpGaD
Pergolide—HTR1A—GPCR downstream signaling—CXCL8—Crohn's disease	4.61e-05	0.000139	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—JAK2—Crohn's disease	4.59e-05	0.000138	CbGpPWpGaD
Pergolide—HTR2C—GPCR downstream signaling—CXCL8—Crohn's disease	4.59e-05	0.000138	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—TYK2—Crohn's disease	4.58e-05	0.000138	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—JAK2—Crohn's disease	4.56e-05	0.000137	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—IL3—Crohn's disease	4.52e-05	0.000136	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—SMAD3—Crohn's disease	4.51e-05	0.000136	CbGpPWpGaD
Pergolide—ADRA2C—GPCR downstream signaling—CXCL8—Crohn's disease	4.46e-05	0.000134	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—JAK2—Crohn's disease	4.44e-05	0.000133	CbGpPWpGaD
Pergolide—DRD2—GPCR downstream signaling—JAK2—Crohn's disease	4.44e-05	0.000133	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—SOCS1—Crohn's disease	4.43e-05	0.000133	CbGpPWpGaD
Pergolide—ADRA1B—GPCR downstream signaling—CXCL8—Crohn's disease	4.39e-05	0.000132	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—RASGRP1—Crohn's disease	4.38e-05	0.000131	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—JAK2—Crohn's disease	4.37e-05	0.000131	CbGpPWpGaD
Pergolide—HTR2A—GPCR downstream signaling—JAK2—Crohn's disease	4.36e-05	0.000131	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—SOCS1—Crohn's disease	4.36e-05	0.000131	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—SMAD3—Crohn's disease	4.35e-05	0.000131	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—CXCL8—Crohn's disease	4.34e-05	0.00013	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—SMAD3—Crohn's disease	4.33e-05	0.00013	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—CXCL8—Crohn's disease	4.33e-05	0.00013	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—JAK2—Crohn's disease	4.27e-05	0.000128	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—SOCS1—Crohn's disease	4.27e-05	0.000128	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—TYK2—Crohn's disease	4.22e-05	0.000127	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—SMAD3—Crohn's disease	4.21e-05	0.000127	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—CXCL8—Crohn's disease	4.19e-05	0.000126	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—IL2RA—Crohn's disease	4.18e-05	0.000125	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—CXCL8—Crohn's disease	4.17e-05	0.000125	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—TYK2—Crohn's disease	4.15e-05	0.000125	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—SMAD3—Crohn's disease	4.15e-05	0.000125	CbGpPWpGaD
Pergolide—DRD5—Signaling by GPCR—IL6—Crohn's disease	4.12e-05	0.000124	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—TYK2—Crohn's disease	4.07e-05	0.000122	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—FADS1—Crohn's disease	4.06e-05	0.000122	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—CXCL8—Crohn's disease	4.05e-05	0.000122	CbGpPWpGaD
Pergolide—DRD2—GPCR downstream signaling—CXCL8—Crohn's disease	4.05e-05	0.000122	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—IL2RA—Crohn's disease	4.03e-05	0.000121	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—JAK2—Crohn's disease	4.03e-05	0.000121	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—IL2RA—Crohn's disease	4.01e-05	0.000121	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—CXCL8—Crohn's disease	3.99e-05	0.00012	CbGpPWpGaD
Pergolide—HTR2A—GPCR downstream signaling—CXCL8—Crohn's disease	3.98e-05	0.00012	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—JAK2—Crohn's disease	3.97e-05	0.000119	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—SOCS1—Crohn's disease	3.96e-05	0.000119	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—JAK2—Crohn's disease	3.96e-05	0.000119	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—IL2RA—Crohn's disease	3.9e-05	0.000117	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—CXCL8—Crohn's disease	3.9e-05	0.000117	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—JAK2—Crohn's disease	3.88e-05	0.000117	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—IL2RA—Crohn's disease	3.84e-05	0.000115	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—SMAD3—Crohn's disease	3.82e-05	0.000115	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—TYK2—Crohn's disease	3.81e-05	0.000114	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GPX4—Crohn's disease	3.8e-05	0.000114	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—TYK2—Crohn's disease	3.78e-05	0.000114	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—SMAD3—Crohn's disease	3.76e-05	0.000113	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—TYK2—Crohn's disease	3.73e-05	0.000112	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—SMAD3—Crohn's disease	3.68e-05	0.000111	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—CXCL8—Crohn's disease	3.68e-05	0.00011	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—TYK2—Crohn's disease	3.67e-05	0.00011	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GCKR—Crohn's disease	3.67e-05	0.00011	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—JAK2—Crohn's disease	3.63e-05	0.000109	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—CXCL8—Crohn's disease	3.62e-05	0.000109	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—CXCL8—Crohn's disease	3.62e-05	0.000109	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—JAK2—Crohn's disease	3.61e-05	0.000108	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—JAK2—Crohn's disease	3.56e-05	0.000107	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—CXCL8—Crohn's disease	3.54e-05	0.000106	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—IL2RA—Crohn's disease	3.54e-05	0.000106	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—TYK2—Crohn's disease	3.5e-05	0.000105	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—JAK2—Crohn's disease	3.5e-05	0.000105	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—IL2RA—Crohn's disease	3.48e-05	0.000105	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—STAT3—Crohn's disease	3.48e-05	0.000105	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—SMAD3—Crohn's disease	3.42e-05	0.000103	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—IL2RA—Crohn's disease	3.41e-05	0.000102	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—ALB—Crohn's disease	3.37e-05	0.000101	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—JAK2—Crohn's disease	3.34e-05	0.0001	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—CXCL8—Crohn's disease	3.32e-05	9.96e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—TYK2—Crohn's disease	3.3e-05	9.92e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—CXCL8—Crohn's disease	3.29e-05	9.89e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—TYK2—Crohn's disease	3.26e-05	9.79e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—TYK2—Crohn's disease	3.26e-05	9.79e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—CXCL8—Crohn's disease	3.25e-05	9.75e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—CXCL8—Crohn's disease	3.19e-05	9.6e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—IL2RA—Crohn's disease	3.17e-05	9.52e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling by GPCR—IL6—Crohn's disease	3.15e-05	9.47e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—JAK2—Crohn's disease	3.15e-05	9.47e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—JAK2—Crohn's disease	3.11e-05	9.34e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—JAK2—Crohn's disease	3.11e-05	9.34e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling by GPCR—IL6—Crohn's disease	3.09e-05	9.28e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—CXCL8—Crohn's disease	3.05e-05	9.16e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling by GPCR—IL6—Crohn's disease	3.04e-05	9.13e-05	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—PTGS2—Crohn's disease	2.95e-05	8.87e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—TYK2—Crohn's disease	2.94e-05	8.84e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling by GPCR—IL6—Crohn's disease	2.9e-05	8.71e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—CXCL8—Crohn's disease	2.88e-05	8.64e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—TYK2—Crohn's disease	2.84e-05	8.53e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—CXCL8—Crohn's disease	2.84e-05	8.53e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—CXCL8—Crohn's disease	2.84e-05	8.53e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—TYK2—Crohn's disease	2.83e-05	8.49e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—JAK2—Crohn's disease	2.81e-05	8.43e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—TYK2—Crohn's disease	2.75e-05	8.26e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—ALB—Crohn's disease	2.74e-05	8.23e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—IL6—Crohn's disease	2.73e-05	8.22e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—JAK2—Crohn's disease	2.71e-05	8.14e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—TYK2—Crohn's disease	2.71e-05	8.13e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—IL6—Crohn's disease	2.7e-05	8.11e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—IL6—Crohn's disease	2.7e-05	8.11e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—JAK2—Crohn's disease	2.7e-05	8.1e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—STAT3—Crohn's disease	2.67e-05	8.01e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—JAK2—Crohn's disease	2.62e-05	7.88e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—STAT3—Crohn's disease	2.61e-05	7.84e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—JAK2—Crohn's disease	2.58e-05	7.75e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—STAT3—Crohn's disease	2.57e-05	7.72e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—CXCL8—Crohn's disease	2.56e-05	7.7e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—TYK2—Crohn's disease	2.49e-05	7.49e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—CXCL8—Crohn's disease	2.47e-05	7.43e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—CXCL8—Crohn's disease	2.46e-05	7.39e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—TYK2—Crohn's disease	2.45e-05	7.37e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—STAT3—Crohn's disease	2.45e-05	7.37e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—IL6—Crohn's disease	2.44e-05	7.32e-05	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—IL6—Crohn's disease	2.43e-05	7.31e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—TYK2—Crohn's disease	2.4e-05	7.22e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—PTGS2—Crohn's disease	2.4e-05	7.2e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—CXCL8—Crohn's disease	2.39e-05	7.19e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—JAK2—Crohn's disease	2.38e-05	7.15e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—CXCL8—Crohn's disease	2.36e-05	7.08e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—IL6—Crohn's disease	2.35e-05	7.07e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—JAK2—Crohn's disease	2.34e-05	7.03e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—IL6—Crohn's disease	2.34e-05	7.03e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—STAT3—Crohn's disease	2.31e-05	6.95e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—JAK2—Crohn's disease	2.29e-05	6.89e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—STAT3—Crohn's disease	2.28e-05	6.86e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—STAT3—Crohn's disease	2.28e-05	6.86e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—IL6—Crohn's disease	2.28e-05	6.84e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—IL6—Crohn's disease	2.24e-05	6.73e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—TYK2—Crohn's disease	2.23e-05	6.71e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CXCL8—Crohn's disease	2.17e-05	6.52e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CXCL8—Crohn's disease	2.14e-05	6.42e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—JAK2—Crohn's disease	2.13e-05	6.4e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CXCL8—Crohn's disease	2.09e-05	6.29e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—IL6—Crohn's disease	2.06e-05	6.2e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—STAT3—Crohn's disease	2.06e-05	6.19e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—IL6—Crohn's disease	2.03e-05	6.1e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—IL6—Crohn's disease	1.99e-05	5.98e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—STAT3—Crohn's disease	1.99e-05	5.98e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—STAT3—Crohn's disease	1.98e-05	5.95e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CXCL8—Crohn's disease	1.94e-05	5.84e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—STAT3—Crohn's disease	1.92e-05	5.78e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—STAT3—Crohn's disease	1.89e-05	5.69e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—IL6—Crohn's disease	1.86e-05	5.6e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—IL6—Crohn's disease	1.85e-05	5.55e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—IL6—Crohn's disease	1.82e-05	5.48e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—IL6—Crohn's disease	1.79e-05	5.39e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—ALB—Crohn's disease	1.79e-05	5.36e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—STAT3—Crohn's disease	1.75e-05	5.25e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—STAT3—Crohn's disease	1.72e-05	5.16e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—IL6—Crohn's disease	1.71e-05	5.15e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—STAT3—Crohn's disease	1.68e-05	5.06e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—IL6—Crohn's disease	1.62e-05	4.85e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—IL6—Crohn's disease	1.59e-05	4.79e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—IL6—Crohn's disease	1.59e-05	4.79e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—STAT3—Crohn's disease	1.56e-05	4.7e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PTGS2—Crohn's disease	1.56e-05	4.69e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—IL6—Crohn's disease	1.44e-05	4.32e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—IL6—Crohn's disease	1.39e-05	4.17e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—IL6—Crohn's disease	1.38e-05	4.15e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—IL6—Crohn's disease	1.34e-05	4.04e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—IL6—Crohn's disease	1.32e-05	3.98e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—IL6—Crohn's disease	1.22e-05	3.66e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—IL6—Crohn's disease	1.2e-05	3.61e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—IL6—Crohn's disease	1.18e-05	3.53e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—ALB—Crohn's disease	1.17e-05	3.51e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—IL6—Crohn's disease	1.09e-05	3.28e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PTGS2—Crohn's disease	1.02e-05	3.07e-05	CbGpPWpGaD
